SPONSOR
University of Oklahoma
Total Trials
12
Recruiting
12
Phases
EARLY_Phase 1, Phase 2, Phase 2, Phase 3, Phase 1, Phase 4
Conditions studied: Healthy AgingFatigueCancer SurvivorshipChemotherapy Side EffectsBreast CancerProstate CancerLymphomaUrothelial CarcinomaSubstance Use DisordersPregnancy Related
University of Oklahoma is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Healthy Aging, Fatigue, Cancer Survivorship, Chemotherapy Side Effects.
The trial portfolio spans EARLY_Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Oklahoma
How many clinical trials has University of Oklahoma sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by University of Oklahoma, of which 12 are actively recruiting participants. These trials cover conditions including Healthy Aging, Fatigue, Cancer Survivorship. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Oklahoma research focus on?
University of Oklahoma clinical trials span Healthy Aging, Fatigue, Cancer Survivorship, Chemotherapy Side Effects, Breast Cancer, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Oklahoma clinical trial?
To participate in a University of Oklahoma trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Oklahoma trials with current recruitment status updated daily.
Clinical Trials by University of Oklahoma
NCT05487131
Recruiting
Neuromodulation and Fatigue
Healthy Aging
NCT06725953
Recruiting
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
Cancer Survivorship
NCT07014618
Recruiting
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Breast Cancer
NCT05921253 EARLY_Phase 1
Recruiting
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Breast Cancer
NCT07183319 Phase 2
Recruiting
Circulating Tumor DNA Response In Urothelial Cancer
Urothelial Carcinoma
NCT05534568
Recruiting
The Oklahoma Parent-Child Assistance Program
Substance Use Disorders
NCT06820034 Phase 2, Phase 3
Recruiting
Empowering Cessation ACS South Region
Smoking Cessation
NCT03541889 Phase 1
Recruiting
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Primary Graft Failure
NCT03845036
Recruiting
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Claudication
NCT07080788
Recruiting
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
Smoking Cessation Intervention
NCT07254910
Recruiting
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
CRC Screening
NCT05587361 Phase 4
Recruiting
Beta-Adrenergic Modulation of Drug Cue Reactivity
Tobacco Use Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology